Showing recent highlights
Lifestyle
PubMed · November 1, 2026
A study found that people with rheumatoid arthritis who followed the DASH diet — an eating plan rich in fruits, vegetables, whole grains, and low-fat dairy, while cutting back on salt, red meat, and added sugars — for 12 weeks saw reductions in disease activity, meaning less joint tenderness, swelling, and pain compared to those who kept their usual diet. Researchers measured joint inflammation and overall well-being at four checkpoints over the 12 weeks and found the DASH group improved more consistently across those measures. The study involved 82 people with a specific confirmed form of rheumatoid arthritis (meaning blood tests showed markers of the disease), though just under half completed all 12 weeks.
What's New
PubMed · November 1, 2026
Researchers found that a drug called peresolimab — which works by activating a natural 'brake' in the immune system called PD-1 — reduced signs of inflammation in people with moderate-to-severe rheumatoid arthritis (a condition where the immune system mistakenly attacks the joints, causing pain and swelling). When scientists looked at blood samples from patients who received the drug, they saw meaningful shifts in immune cells and proteins linked to inflammation, which helps explain why the drug seemed to ease symptoms in an earlier trial. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that tofacitinib — a medication used to treat rheumatoid arthritis — may help lower levels of a protein in the blood called KL-6, which doctors use as a marker to track how much damage is happening in the lungs of people with rheumatoid arthritis-related lung disease (a condition where the lungs gradually scar and stiffen over time). The study also found that about half of patients reached low disease activity, meaning their arthritis became less active, though serious events including deaths and worsening lung disease still occurred in a notable number of participants. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that total elbow replacement surgery — where a damaged elbow joint is replaced with an artificial one — led to meaningful improvements in pain and movement for patients, and that the most common reason people needed this surgery was rheumatoid arthritis, a condition where the immune system attacks the joints. Over the long term, roughly 86 out of 100 artificial elbows were still working without needing to be replaced after at least 7 years, though about 1 in 6 patients needed some form of additional surgery for various reasons. This is early research and hasn't yet changed treatment guidelines.
Medications
ScienceDaily · October 27, 2026
A press release reports that JAK inhibitors — a group of medications used to treat rheumatoid arthritis (a condition where the immune system attacks the joints) — may have an unexpected downside. These drugs appear to quiet certain genes that the body normally uses to fight off viruses like the flu and COVID-19, which could make people taking them more vulnerable to serious infections. This appears to be a safety-related finding worth being aware of, and people taking these medications may want to discuss any concerns with their doctor.
Ask your doctor: Ask the doctor whether the patient's JAK inhibitor medication for rheumatoid arthritis might make it harder for the patient's body to fight off flu or COVID-19.
What's New
JAMA · October 13, 2026
Researchers reviewed what we know about rheumatoid arthritis in adults — including what causes it, who gets it, how it's diagnosed, and how it's treated. For someone living with this condition, a broad review like this can help paint a fuller picture of why the disease behaves the way it does and what factors might affect long-term outcomes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that people with rheumatic diseases — conditions like rheumatoid arthritis or lupus where the immune system attacks the body — who take hydroxychloroquine (a common treatment) for many years have a small but growing risk of developing eye damage (where the medication gradually harms the retina, the light-sensitive layer at the back of the eye). The risk stayed very low in the first five years but rose to about 1 in 18 people after 15 years of use, and the risk was higher for those taking larger daily doses, women, and people with kidney disease. This matters because eye damage from this medication can sometimes be permanent, so understanding who is most at risk could help patients and their doctors have more informed conversations about monitoring. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should have their eyes checked with special imaging to look for vision problems from taking hydroxychloroquine long-term for rheumatoid arthritis.
What's New
PubMed · October 1, 2026
Researchers found that when people have both rheumatoid arthritis and a second joint condition called calcium pyrophosphate deposition disease — where calcium crystals build up in the joints, causing pain and swelling — it tends to happen almost exclusively in older adults, with nearly all of the 404 patients studied being over 60 years old. Interestingly, the majority of these patients tested negative for the usual blood markers doctors look for when diagnosing rheumatoid arthritis, which could make the condition harder to identify and treat correctly. This matters because if a doctor only relies on blood tests, they might miss the diagnosis in someone who actually has both conditions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that combining two traditional Chinese herbal formulas — Qushi Juanbi Granules and Shenling Baizhu Powder — may help people with rheumatoid arthritis (a condition where the immune system attacks the joints, causing pain and swelling) who still have some mild disease activity despite treatment. The combination appeared to reduce joint tenderness, swelling, and morning stiffness more than one of the formulas used alone. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that even when people with rheumatoid arthritis reach their treatment goals — like being in remission or having low disease activity — many still experience lingering symptoms such as swollen joints, pain, or fatigue. For example, up to 25% of people in remission still had swollen joints, and as many as one in three reported ongoing symptoms like tiredness or difficulty with everyday tasks. This matters because it suggests that reaching a treatment target doesn't always mean a person feels fully well, which could open conversations between patients and their doctors about what 'good enough' really means. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that taking creatine — a natural supplement often used by athletes — may help people with rheumatoid arthritis build muscle and possibly reduce disease activity, which refers to how active and aggressive the inflammation in the joints is. The findings were small and early, coming from only a handful of studies with limited numbers of participants, so it's hard to draw firm conclusions yet. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that people with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and inflammation — who received aromatherapy massage reported less anxiety and fewer feelings of depression compared to those who received no massage at all. However, when researchers compared aromatherapy massage to a plain massage without essential oils, the difference in benefit was not clear-cut, suggesting the soothing effect of massage itself may be playing a big role. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that practicing yoga may help people with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and inflammation — by improving their mental well-being and lowering levels of a key inflammation marker in the blood called interleukin-6. The analysis looked at eight studies involving 651 participants and found these benefits compared to people who didn't do yoga, though it didn't show a clear improvement in day-to-day physical functioning. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that for people with rheumatoid arthritis — a condition where the immune system attacks the joints — reducing or stopping their long-term medications was linked to a higher chance of the disease flaring up again, meaning symptoms like pain and swelling coming back. Stopping the medication completely roughly doubled the risk of a flare compared to staying on the full dose, and there were also signs that joint damage continued to progress in people who tapered or stopped. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that for people newly diagnosed with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and swelling — starting on newer biologic medications alongside a standard drug called methotrexate led to significantly higher rates of remission (meaning little to no active disease) compared to methotrexate alone, especially in people whose arthritis was more severe at the start of treatment. This could matter because reaching remission early may help protect joints from long-term damage. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that a medication called certolizumab, when combined with methotrexate (a common arthritis drug), helped slow joint damage in people with early rheumatoid arthritis — even in those with very high levels of rheumatoid factor, a blood marker that often signals more aggressive disease. People with high rheumatoid factor who took the combination had similar, low rates of joint damage compared to those with lower rheumatoid factor levels, while those who took methotrexate alone with high rheumatoid factor fared noticeably worse. This is early research and hasn't yet changed treatment guidelines.
What's New
ScienceDaily · September 27, 2026
A press release highlights that people with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and swelling — may still feel pain and tiredness even after their inflammation is well managed. Hidden factors like depression, poor sleep, obesity, and smoking may be keeping those symptoms alive. Recognizing these underlying causes could help doctors avoid unnecessary medication changes and find more targeted ways to help each person feel better.
What's New
PubMed · September 1, 2026
Researchers found that a structured self-management program — where people with chronic conditions like type 2 diabetes learn skills to manage their health day-to-day — led to lasting improvements in sleep, pain, fatigue, and mood, even six months after the program ended, across many different countries. For someone with type 2 diabetes, this matters because managing a long-term condition involves a lot more than just medication — things like energy levels, sleep, and emotional well-being all affect how well someone can stay on top of their health. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · September 1, 2026
A study found that women with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and stiffness — who practiced yoga for 8 weeks in a row reported noticeably less pain, better balance, less fatigue, and improved mood compared to women who did a mixed exercise program or no structured exercise at all. The yoga group's pain scores dropped about twice as much as those in the combined exercise group, and these benefits were still measurable 20 weeks after the program ended. Researchers think the breathing and relaxation techniques built into yoga may be a big part of why it worked so well.
What's New
PubMed · September 1, 2026
Researchers found that people with rheumatoid arthritis who have a higher body weight (measured by BMI, a ratio of weight to height) may respond less well to a group of medications called JAK inhibitors — which includes drugs like tofacitinib and baricitinib — compared to people with a lower body weight. This was discovered by pooling and re-analyzing data from 16 separate studies involving nearly 12,000 patients, making it one of the largest looks at this question so far. For someone living with rheumatoid arthritis and managing their weight, this could be an important piece of the puzzle when talking with their doctor about which treatment might work best for them. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that gently stimulating a nerve near the base of the spine — using thin needles similar to acupuncture — may help calm the nervous system in people with rheumatoid arthritis, a condition where the immune system attacks the joints causing pain and swelling. People who received the real stimulation showed signs of improved nervous system balance, which is interesting because an out-of-balance nervous system is thought to make inflammation worse. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · September 1, 2026
According to American College of Rheumatology guidelines, exercise is recommended for adults with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and stiffness — because it has been shown to improve physical function and reduce pain compared to no exercise. This new analysis looked at whether the evidence behind that recommendation is solid enough to be considered settled, and found that while the results are promising, more research is still needed before experts can say with full confidence that the picture is complete. For now, the guideline's support for exercise remains based on moderate-strength evidence, meaning it's a well-supported recommendation but not yet the final word.
What's New
PubMed · September 1, 2026
Researchers found that two types of hands-on physical therapy — one focusing on muscles and soft tissue, the other on gently moving the joints themselves — both helped people with rheumatoid arthritis who also had jaw joint problems (a condition called temporomandibular disorder, where the jaw joint causes pain or stiffness). After six weeks of twice-weekly sessions, people in both therapy groups could open and move their jaws more freely and reported lower anxiety levels, while people who received no treatment actually got a little worse over time. This matters because jaw problems are common in rheumatoid arthritis and are sometimes overlooked, so knowing that hands-on therapy may help could be encouraging for people dealing with both conditions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that people with chronic pain conditions — including fibromyalgia, rheumatoid arthritis, and knee or hip osteoarthritis — reported improvements in pain, mental health, and physical functioning after taking capsules containing different combinations of cannabis compounds over 12 weeks. All three formulas tested showed benefits, though none stood out as clearly superior to the others. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that people with early rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and swelling — who had higher levels of a natural protein called interleukin-10 in their blood were more likely to respond well to a medication called abatacept, and also showed less joint bone damage over time. This suggests that a simple blood marker might one day help doctors predict which patients are most likely to benefit from this particular treatment before they even start it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that people with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and swelling — use physical and occupational therapy at very different rates depending on where they live, with people in European countries generally receiving these services more often than those in North America. The review also found that physical therapy was used far more than occupational therapy, which helps people manage daily tasks affected by their condition. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that a shot given just under the skin may work as well as an IV drip for delivering an ultra-low dose of rituximab — a medication used to treat rheumatoid arthritis, a condition where the immune system attacks the joints. This matters because a simple injection could be more convenient, potentially carry a lower risk of infection, and cost less than a traditional IV treatment. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 31, 2026
Researchers found that Japanese patients with rheumatoid arthritis — a condition where the immune system attacks the joints, causing pain and swelling — who took a medication called upadacitinib on its own did better over five years than those who took methotrexate, a commonly used treatment, on its own. People taking upadacitinib also had less joint damage building up over time, which matters because joint damage can affect movement and quality of life in the long run. The higher dose of upadacitinib did come with more side effects, so this is something people with rheumatoid arthritis might want to discuss with their doctor. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 31, 2026
Researchers found that filgotinib, a medication used to treat moderate to severe rheumatoid arthritis, appeared to be well-tolerated over up to 5 years in a group of Japanese patients — with no cases of dangerous blood clots and very few deaths reported during that time. The most notable side effects were serious infections and a viral condition called herpes zoster (a painful skin rash related to the chickenpox virus), though these occurred at relatively low rates. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 31, 2026
Researchers found that people with rheumatoid arthritis — a condition where the immune system attacks the joints — who took a newer biologic treatment called ozoralizumab sometimes developed antibodies against the drug itself, which could weaken how well it worked. However, when ozoralizumab was taken alongside a common companion drug called methotrexate, those drug-fighting antibodies were less likely to form, and the treatment kept working better for longer. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.